Member Info for bbrq648

Kainos,
Why invest in BRH, if you are spreading rumours about the CEO of this Company?
If so wished, invest and keep your cool.
All LTHs are happy and major investment are held by PI and Traders and IIs.
Hereafter if you post rumours here in this board, we may have to filer you or tell LSE to block you.

bbrq648

DaProphet,
There is only one way as the Clinical Validation is based on BRH Clinical Trials conducted, with possibilities of minor upgrade to improve the range of applicability.
bbrq648

Robbo13,
You are filtered for writing sarcastic posts, and religion into this BB.
Jokingly or not no excuses.

bbrq648

As predicted BRH share price to move northwards.
LTH make this buying opportunity befor COT today.

bbrq648

LTH,
Looks like demands are high and allowing to sell in IWEB, but buys don’t go into auto trade display prices.
Hold on to your valuable shares, and maximum only two weeks prior to receipt of many interesting RNSs from BRH.

bbrq648

Rocky500,
Well said.
Nothing more to add to what was posted by you below.

bbrq648

Why BRH/ Paraytec Test is best currently in the world, undergoing Clinical Validation?
Clinical validation is going successfully and about to complete before end of April 2021.
Just a couple of weeks only left.

The deficiencies of the LFT and RT-PCR tests have been known to Paraytec and Prof. Carl Smythe and his team.

During the Fast track Paraytec LFT and Multiplex Matrix Test Development, the Test performance have taken into consideration of sensitivity and specificity as well as the presence of level of viral load to lower levels to pick-up pre-symptomatic and asymptomatic persons identified and isolated in advance to stop spreading the COVID-19 viruses in public places.
As the symptomatic cases have high viral load had good detection with false negative and false positives. These issues were also addressed during the BRH/ Paraytec Test development.

Furthermore, proper and easy sampling techniques put in place to identify tests are invalid cases, and to repeat the test. This will be addressed in the sampling technique to be used for both the tests.

DHSC had tightened the testing ranges and viral loads to pick-up pre-symptomatic and asymptomatic cases more accurately in their latest specification.

BRH RNSs dated 01-Mar-2021 and 26-Mar-2021 clearly stated the interim trial test conducted, and refined as appropriate to meet or exceed the DHSC specific requirements.

Thus, even with the delay in testing and with additional platform technology to potentially identify/ detect multiple virus targets will be the only market leader in Fast, Accurate and Sensitive test available very soon.

Forecast date: Before or End of April 2021.
Even with a month delay, this BRH/Paraytec Test is going to be the market leader.

With UKCA, CE, FDA approvals, PHA Test Validation, Approvals, Partner(s), Manufacturers licences and Contracts are still outstanding and will be forthcoming in successive RNSs from BRH/Paraytec.

This is a buying opportunity with the unusual price fluctuation yesterday. LTHs have made use of 62p drop and bought them. Those who bought yesterday, please hold them till the share price to move back to £1.40 and then gradually move northward (increase) with steady positive news.

By then the Alzheimer’s and Sepsis Tests would progress successfully to further increase in BRH share value.

Good Luck to LTH.
bbrq648

Few derampers still left for fishing here.
Leave the PI and this board alone, and the BRH/ Paraytec LFT and Matrix Testing is going to clear the issues related to the existing LFTs which cannot resolve False Positive and False Negative Tests.
I will post why BRH/ Paraytec is going to be the Gold Standard LFTs and better than PCR Test as well.
bbrq648

Jodrell13,
Tell us what is your plan.
Why are you not sending your messages?
Let us hear, what you want to say.

bbrq648

Buythedip1984,
You are Filtered for using Pure Deramp Technique.

LTH
bbrq648

Bet3990,
You are Filtered.
Pure form of deramp.
bbrq648

Bet3990,
You are Filtered.
Pure form of deramp.
bbrq648

Why is price drop suddenly with less than 10000 & 40000?
Whereas more than 500,000 share sale price was static.
Can the MM explain why, and if there are large sales from Insiders, will the TR1 forthcoming early morning at 7:00AM?
If it is a normal sale, then this would have been reflected in the BRH L2 as well as daily buys and sells. Even though the share price algorithm is automatically setting the price, some additional information missing for the PIs, and not shown in the buys & sells.
Correction needed in the BRH L2 display console.

bbrq648

bbrq648

DaProphet,
Hold your horse.
Wait for any TR1 before hypothetically posting in this BB.
bbrq648

HeresHopin,
If you have shares then either average down or stay safe.
Don’t post saying Rampers.
LTH are watching and making use of share price movements and either average down or not topping up.
bbrq648

HeresHopin,
Why are you here?
Do you invest here to make money? Else why waste time.
If not, Are you paid by others?
Else, you won’t waste your valuable time.
bbrq648

DrMicho,
Fact of the matter is all the sells were bought yesterday by LTH, Traders and IIs.
Most of us in this BB knows an RNS will make its way 2nd day, i.e., tomorrow if this was insider trading.
bbrq648

The deficiencies of the LFT and RT-PCR tests have been known to Paraytec and Prof. Carl Smythe and his team.

During the Fast track Paraytec LFT and Multiplex Matrix Test Development, the Test performance have taken into consideration of sensitivity and specificity as well as the presence of level of viral load to lower levels to pick-up pre-symptomatic and asymptomatic persons identified and isolated in advance to stop spreading the COVID-19 viruses in public places.
As the symptomatic cases have high viral load had good detection with false negative and false positives. These issues were also addressed during the BRH/ Paraytec Test development.

Furthermore, proper and easy sampling techniques put in place to identify tests are invalid cases, and to repeat the test. This will be addressed in the sampling technique to be used for both the tests.

DHSC had tightened the testing ranges and viral loads to pick-up pre-symptomatic and asymptomatic cases more accurately in their latest specification.

BRH RNSs dated 01-Mar-2021 and 26-Mar-2021 clearly stated the interim trial test conducted, and refined as appropriate to meet or exceed the DHSC specific requirements.

Thus, even with the delay in testing and with additional platform technology to potentially identify/ detect multiple virus targets will be the only market leader in Fast, Accurate and Sensitive test available very soon.

Forecast date: Before or End of April 2021.
Even with a month delay, this BRH/Paraytec Test is going to be the market leader.

With UKCA, CE, FDA approvals, PHA Test Validation, Approvals, Partner(s), Manufacturers licences and Contracts are still outstanding and will be forthcoming in successive RNSs from BRH/Paraytec.

This is a buying opportunity with the unusual price fluctuation yesterday. LTHs have made use of 62p drop and bought them. Those who bought yesterday, please hold them till the share price to move back to £1.40 and then gradually move northward (increase) with steady positive news and RNSs.

By then the Alzheimer’s and Sepsis Tests would progress successfully to further increase in BRH share value.

Good Luck to LTH.
bbrq648

As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare.

DaProphet,
For the second part regarding approximately 25% sale by TM and VM of their respective holdings, there are several reasons for it, but not insider dealing knowing that current forecast as you have wrote it.
I hope you know from this BB posted for other reasons behind the sale.
Hope this clarifies the matter.

bbrq648